
Temsujohn 0.2mg Tablet ER
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Tamsulosin (0.2mg)
Overview Temsujohn 0.2mg Tablet ER
Alfuzosin extended-release 0.2mg tablets are alpha-blockers indicated for benign prostatic hyperplasia (BPH). This medication alleviates urinary symptoms such as hesitancy, but doesn't reduce prostate volume. Always follow your physician's prescribed dosage and schedule. It can be taken with or without food, but maintain consistent timing. Swallow the tablet whole; do not crush or chew. Discontinue use only under medical supervision, as abrupt cessation may worsen symptoms. Complete the prescribed course for optimal results. Common side effects include lightheadedness, back discomfort, chest pain, impaired ejaculation, and retrograde ejaculation. Report any persistent or bothersome side effects promptly to your doctor. Lifestyle adjustments can improve symptom management. Urinate when you feel the need, but avoid straining. Limit or avoid caffeinated and alcoholic beverages close to bedtime. Prior to treatment, disclose all other medications and health conditions to your doctor. If undergoing cataract or glaucoma surgery, inform your ophthalmologist about alfuzosin use. Patients with hepatic impairment should exercise caution, receiving regular monitoring as directed by their physician.
Uses of Temsujohn 0.2mg Tablet ER
Managing benign prostatic enlargement
Major Benefits of Temsujohn 0.2mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Temsujohn 0.2mg Extended-Release Tablet can be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Temsujohn 0.2mg Tablet ER:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Temsujohn 0.2mg Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Temsujohn 0.2mg Extended-Release Tablet can be consumed with or without food, though consistent daily timing is recommended.
How Temsujohn 0.2mg Tablet ER works:
Temsujohn 0.2mg Extended-Release tablets function as an alpha-adrenergic antagonist. By relaxing the muscles in the bladder neck and prostate, they facilitate smoother urine flow, promoting complete bladder emptying and lessening the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Temsujohn 0.2mg Extended-Release tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The safety of Temsujohn 0.2mg Extended-Release Tablet during pregnancy is unknown. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Employing Temsujohn 0.2mg Extended-Release Tablets while breastfeeding is likely unsafe. Available human data suggests potential drug transfer via breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.
DrivingSAFE
Driving ability is typically unaffected by Temsujohn 0.2mg Extended-Release Tablets.
KidneySAFE IF PRESCRIBED
Temsujohn 0.2mg Extended-Release tablets are considered safe for individuals with kidney impairment; no dosage modification is typically necessary. Nevertheless, data regarding its use in patients experiencing end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Temsujohn 0.2mg Extended-Release tablets. Dosage modification of Temsujohn 0.2mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Temsujohn 0.2mg Tablet ER :
Should you forget to take a Temsujohn 0.2mg Extended-Release Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Temsujohn 0.2mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
